tiprankstipranks
Pharmaust Limited (AU:NUZ)
ASX:NUZ
Australian Market

Pharmaust Limited (NUZ) Technical Analysis

Compare
21 Followers

Summary of all the Indicators

Overall Consensus
Neutral
8Bullish
6Neutral
8Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Sell
5Bullish
0Neutral
7Bearish
Pharmaust Limited’s (NUZ) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Pharmaust Limited is a Sell.
Pharmaust Limited’s (NUZ) 20-Day exponential moving average is 0.14, while Pharmaust Limited’s (NUZ) share price is AU$0.14, making it a Buy.
Pharmaust Limited’s (NUZ) 50-Day exponential moving average is 0.15, while Pharmaust Limited’s (NUZ) share price is AU$0.14, making it a Sell.

Pharmaust Limited (NUZ) Pivot Points

Feb 23, 2025, 02:23 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.14
0.14
0.14
0.15
0.15
0.15
0.15
Fibonacci
0.14
0.14
0.14
0.15
0.15
0.15
0.15
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaust Limited (NUZ) Moving Averages

Feb 23, 2025, 02:23 AM
Period
Simple
Exponential
MA5
0.15Sell
0.14Buy
MA10
0.14Buy
0.14Buy
MA20
0.14Buy
0.14Buy
MA50
0.15Sell
0.15Sell
MA100
0.17Sell
0.17Sell
MA200
0.18Sell
0.19Sell
Pharmaust Limited’s (NUZ) 10-Day exponential moving average is 0.14, while Pharmaust Limited’s (NUZ) share price is AU$0.14, making it a Buy.
Pharmaust Limited’s (NUZ) 100-Day exponential moving average is 0.17, while Pharmaust Limited’s (NUZ) share price is AU$0.14, making it a Sell.
Pharmaust Limited’s (NUZ) stock price is AU$0.14 and Pharmaust Limited’s (NUZ) 50-day simple moving average is 0.15, creating a Sell signal.
Pharmaust Limited’s (NUZ) stock price is AU$0.14 and Pharmaust Limited’s (NUZ) 100-day simple moving average is 0.17, creating a Sell signal.
Pharmaust Limited’s (NUZ) stock price is AU$0.14 and Pharmaust Limited’s (NUZ) 200-day simple moving average is 0.18, creating a Sell signal.

Pharmaust Limited (NUZ) Technical Indicators

Feb 23, 2025, 02:23 AM
Name
Value
Implied Action
RSI (14)
51.02
Neutral
STOCH (9,6)
50.00
Neutral
STOCHRSI (14)
58.27
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
25.73
Neutral
Williams %R
-42.86
Buy
CCI (14)
89.25
Neutral
ATR (14)
0.01
-
Ultimate Oscillator
42.46
Neutral
ROC
16.00
Buy
Pharmaust Limited’s (NUZ) Relative Strength Index (RSI) is 51.02, creating a Neutral signal.
Pharmaust Limited’s (NUZ) Trend Strength Indicator (ADX) is 25.73, creating a Neutral signal.
Pharmaust Limited’s (NUZ) Commodity Channel Index (CCI) is 89.25, creating a Neutral signal.
Pharmaust Limited’s (NUZ) Price Rate of Change (ROC) is 16.00, creating a Buy signal.

FAQ

Is NUZ a Buy, Hold, or Sell?
Based on NUZ’s technical indicators, NUZ is a Hold.
    What is NUZ’s RSI (14)?
    NUZ’s RSI (14) is 51.02, which suggests NUZ is a Neutral.
      What is NUZ’s MACD?
      NUZ’s MACD is >-0.01, which suggests NUZ is a Sell.
        What is NUZ’s 5-day moving average?
        NUZ’s 5-day moving average is 0.15, which suggests NUZ is a Sell.
          What is NUZ’s 20-day moving average?
          NUZ 20-day moving average is 0.14, which suggests NUZ is a Buy.
            What is NUZ’s 50-day moving average?
            NUZ’s 50-day moving average is 0.15, which suggests NUZ is a Sell.
              What is NUZ’s 200-day moving average?
              NUZ’s 200-day moving average is 0.18, which suggests NUZ is a Sell.
                What is NUZ’s Williams % R (14)?
                NUZ’s Williams % R (14) is -42.86, which suggests NUZ is a Buy.
                  What is NUZ’s CCI (14)?
                  NUZ’s CCI (14) is 89.25, which suggests NUZ is a Neutral.
                    What is the share price of Pharmaust Limited?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis